[
  {
    "ts": null,
    "headline": "Thermo Fisher Q4 Beat Highlights Bioproduction Strength And Product-Led Growth Shift",
    "summary": "Thermo Fisher Scientific (NYSE:TMO) reported strong fourth quarter results, with performance ahead of expectations. New products, including the Orbitrap Astro Zoom mass spectrometer and DynaDrive bioreactor, contributed to revenue strength. Bioproduction and clinical research segments were key drivers, while academic and some industrial markets faced growth concerns. Thermo Fisher Scientific, a major supplier of instruments, consumables and services to labs and drug developers, sits at the...",
    "url": "https://finnhub.io/api/news?id=26350591c1d63d63c445bfeddf90caa6a7b305727670ab7dec12c2875f05ba07",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770423356,
      "headline": "Thermo Fisher Q4 Beat Highlights Bioproduction Strength And Product-Led Growth Shift",
      "id": 138381760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Thermo Fisher Scientific (NYSE:TMO) reported strong fourth quarter results, with performance ahead of expectations. New products, including the Orbitrap Astro Zoom mass spectrometer and DynaDrive bioreactor, contributed to revenue strength. Bioproduction and clinical research segments were key drivers, while academic and some industrial markets faced growth concerns. Thermo Fisher Scientific, a major supplier of instruments, consumables and services to labs and drug developers, sits at the...",
      "url": "https://finnhub.io/api/news?id=26350591c1d63d63c445bfeddf90caa6a7b305727670ab7dec12c2875f05ba07"
    }
  }
]